Mosaic ImmunoEngineering (OTCMKTS:CPMV) Stock Price Down 5.2% – Here’s What Happened

Shares of Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) fell 5.2% during mid-day trading on Thursday . The stock traded as low as $0.6388 and last traded at $0.6388. Approximately 224 shares changed hands during mid-day trading, an increase of 1,782% from the average daily volume of 12 shares. The stock had previously closed at $0.6740.

Mosaic ImmunoEngineering Trading Down 5.2%

The firm has a 50 day simple moving average of $0.66 and a 200 day simple moving average of $0.60. The firm has a market capitalization of $4.62 million, a PE ratio of -7.10 and a beta of -0.92.

Mosaic ImmunoEngineering (OTCMKTS:CPMV) last posted its quarterly earnings results on Wednesday, May 20th. The company reported ($0.02) earnings per share for the quarter.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.

Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.